KRYS | Krystal Biotech, Inc. | $4.28B | $148.09 | 0.41% |
LEGN | Legend Biotech Corporation | $3.89B | $42.23 | 1.54% |
ACLX | Arcellx, Inc. | $3.82B | $69.39 | 2.67% |
BEAM | Beam Therapeutics Inc. | $2.11B | $21.03 | 1.35% |
SRPT | Sarepta Therapeutics, Inc. | $1.31B | $13.32 | 5.36% |
DYN | Dyne Therapeutics, Inc. | $1.30B | $9.17 | 1.66% |
SANA | Sana Biotechnology, Inc. | $1.00B | $4.44 | 4.10% |
REPL | Replimune Group, Inc. | $950.09M | $12.32 | 1.94% |
IOVA | Iovance Biotherapeutics, Inc. | $831.50M | $2.49 | 11.66% |
MGTX | MeiraGTx Holdings plc | $698.38M | $8.69 | 0.81% |
STOK | Stoke Therapeutics, Inc. | $672.09M | $12.31 | 6.88% |
TSHA | Taysha Gene Therapies, Inc. | $661.67M | $2.53 | 1.56% |
PRME | Prime Medicine, Inc. | $600.02M | $4.57 | 10.65% |
SLDB | Solid Biosciences Inc. | $493.77M | $6.37 | 0.31% |
RGNX | REGENXBIO Inc. | $427.80M | $8.49 | 4.04% |
FULC | Fulcrum Therapeutics, Inc. | $383.25M | $7.10 | 7.19% |
ARCT | Arcturus Therapeutics Holdings Inc. | $373.99M | $13.79 | 2.15% |
ABEO | Abeona Therapeutics Inc. | $345.31M | $6.75 | 2.43% |
RCKT | Rocket Pharmaceuticals, Inc. | $337.22M | $3.13 | 2.96% |
PASG | Passage Bio, Inc. | $327.52M | $5.27 | 5.22% |
RNAC | Cartesian Therapeutics, Inc. | $312.75M | $12.05 | 1.77% |
NGNE | Neurogene Inc. | $308.92M | $21.66 | 3.04% |
BNTC | Benitec Biopharma Inc. | $293.48M | $11.18 | 1.27% |
ALLO | Allogene Therapeutics, Inc. | $288.72M | $1.32 | 5.60% |
TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
EDIT | Editas Medicine, Inc. | $263.70M | $3.15 | 14.13% |
TRDA | Entrada Therapeutics, Inc. | $233.03M | $6.14 | 1.92% |
DSGN | Design Therapeutics, Inc. | $229.91M | $4.05 | 1.76% |
LRMR | Larimar Therapeutics, Inc. | $208.73M | $3.26 | 1.56% |
CRGX | CARGO Therapeutics, Inc. Common Stock | $208.43M | $4.52 | 1.09% |
FDMT | 4D Molecular Therapeutics, Inc. | $196.42M | $4.24 | 0.47% |
TIL | Instil Bio, Inc. | $181.19M | $27.62 | 5.82% |
KYTX | Kyverna Therapeutics, Inc. | $167.26M | $3.87 | 0.77% |
CABA | Cabaletta Bio, Inc. | $147.51M | $1.64 | 1.80% |
LYEL | Lyell Immunopharma, Inc. | $140.53M | $9.49 | 2.71% |
TNYA | Tenaya Therapeutics, Inc. | $139.34M | $0.86 | 2.34% |
NKTX | Nkarta, Inc. | $136.24M | $1.92 | 0.52% |
FATE | Fate Therapeutics, Inc. | $131.83M | $1.15 | 1.77% |
LXEO | Lexeo Therapeutics, Inc. Common Stock | $131.46M | $3.96 | 4.58% |
KRRO | Korro Bio, Inc. | $125.27M | $13.34 | 2.41% |
SGMO | Sangamo Therapeutics, Inc. | $121.38M | $0.49 | 3.06% |
INKT | MiNK Therapeutics, Inc. | $78.92M | $19.80 | 2.51% |
ATRA | Atara Biotherapeutics, Inc. | $78.15M | $11.50 | 15.00% |
ARTV | Artiva Biotherapeutics, Inc. | $62.13M | $2.55 | 6.69% |
ACET | Adicet Bio, Inc. | $61.21M | $0.74 | 2.57% |
ADVM | Adverum Biotechnologies, Inc. | $56.61M | $2.71 | 2.17% |
DTIL | Precision BioSciences, Inc. | $51.56M | $4.65 | 0.87% |
BLUE | bluebird bio, Inc. | $48.67M | $4.97 | 0.00% |
PEPG | PepGen Inc. | $43.19M | $1.32 | 2.22% |
GBIO | Generation Bio Co. | $28.22M | $0.42 | 3.62% |
CARM | Carisma Therapeutics, Inc. | $16.29M | $0.39 | 0.61% |
ERNA | Eterna Therapeutics Inc. | $14.43M | $1.96 | 1.01% |
PHIO | Phio Pharmaceuticals Corp. | $11.47M | $2.39 | 2.45% |
GNPX | Genprex, Inc. | $7.54M | $0.26 | 6.07% |
TCRT | Alaunos Therapeutics, Inc. | $6.13M | $3.10 | 4.32% |